Kurt Von Emster, Director at CymaBay Therapeutics, Inc. (CBAY), sold 37,662 shares at $12.14 ($457K) on 2018-02-05, disclosed to the SEC on 2018-02-07.
Open-market sale of $457k CBAY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.14 | 18,831 | $229K | 50.0% |
| 2 | $12.14 | 18,831 | $229K | 50.0% |
| Total | $12.14 avg | 37,662 | $457K | 100% |
| Filing → |
| VERA | BUY | 2021-05-18 | $8.9M | — | Filing → |
| PCVX | BUY | 2020-06-18 | $200K | — | Filing → |
| CRSP | SELL | 2019-01-18 | $3.7M | — | Filing → |